Trigger-day progesterone-to-mature-oocyte ratio, cycle-level blastocyst yield, and recorded embryo-transfer outcomes: a retrospective cohort study
- 1Department of Clinical Laboratory, Liuzhou Hospital, Guangzhou Women and Children’s Medical Center
- 2Department of Clinical Laboratory, Guigang Clinical Medical Research Center for Medical Laboratory, Guigang City People’s Hospital
- 3Liuzhou Municipal Liutie Central Hospital
Abstract
Background: The progesterone-to-metaphase II oocyte ratio (P/MII) combines trigger-day progesterone with mature oocyte count after retrieval. Its associations may reflect ovarian response and embryo allocation.
Methods: This retrospective cohort included 7,778 in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycle records. Existing pregnancy analyses used 4,273 positive-transfer records. A linked clinical and laboratory source export enabled post hoc analyses using recorded extended culture counts, retrieval order, transfer dates, thawing records, and source-identifier grouping.
Results: The original high-versus-low P/MII rate ratio for blastocysts per recorded 2PN zygote was 0.796 (95% CI 0.762–0.831). Among the same 5,821 culture-positive records, the adjusted rate ratio was 0.934 (0.902–0.968) with a 2PN denominator and 0.974 (0.945–1.005; P = 0.101) with the recorded culture denominator. The continuous culture-count association remained small (aRR 0.993 per 0.01, 0.989–0.997). The source recorded 6,148 first and 1,630 later retrievals. In 3,526 first-retrieval, date-consistent records without thawing evidence, the ratio term after inclusion of progesterone and MII was associated with clinical pregnancy flags (aOR 0.952, 0.919–0.986; P = 0.006) but was uncertain for live birth flags (0.968, 0.935–1.002; P = 0.067). Source-identifier-grouped live birth areas under the receiver operating characteristic curve (AUCs) were 0.623 with the components, 0.623 with P/MII, and 0.624 with all three.
Conclusions: Recorded associations depended on the culture population, denominator, and outcome. Incremental clinical usefulness was not established. These data do not support a physiological ratio mechanism or a clinical cutoff for trigger-day or freeze-all decisions.
Related
- Sequential blastocyst transfer improved pregnancy outcomes in patients undergoing frozen-thawed embryo transfer cycles: who will be the ultimate beneficiary
- Effect of the 'Ready-to-Use Vitrification and Warming Kit' on Pregnancy Rates Following Vitrification-warmed Blastocyst Transfer: A Retrospective Study.
- Genetic and non-genetic contributions to early spontaneous miscarriage in women with PCOS undergoing PGT-A and single euploid blastocyst transfer: a retrospective cohort study
- Recorded Adverse Events and Patient-Reported Outcomes After Intra-articular Extracellular-Vesicle Product Administration for Knee Osteoarthritis: A Retrospective Single-Practice Case Series
- Progesterone levels on hCG trigger day and neonatal outcomes in fresh embryo transfers: a retrospective threshold analysis of GnRH antagonist versus agonist long protocols.
BibTeX
@article{wei2026triggerday,
title = {{Trigger-day progesterone-to-mature-oocyte ratio, cycle-level blastocyst yield, and recorded embryo-transfer outcomes: a retrospective cohort study}},
author = {Yidong Wei and Yu Xu and Nuanfang Wei and Yu Chen and Yupei Zhang and Xueli Li and Haifan Wei},
journal = {Frontiers in Endocrinology},
year = {2026},
month = oct,
doi = {10.3389/fendo.2026.1938120},
url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1938120/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Trigger-day progesterone-to-mature-oocyte ratio, cycle-level blastocyst yield, and recorded embryo-transfer outcomes: a retrospective cohort study
AU - Yidong Wei
AU - Yu Xu
AU - Nuanfang Wei
AU - Yu Chen
AU - Yupei Zhang
AU - Xueli Li
AU - Haifan Wei
PY - 2026
DA - 2026/10/28
JO - Frontiers in Endocrinology
DO - 10.3389/fendo.2026.1938120
UR - https://www.frontiersin.org/articles/10.3389/fendo.2026.1938120/full
AB - Background: The progesterone-to-metaphase II oocyte ratio (P/MII) combines trigger-day progesterone with mature oocyte count after retrieval. Its associations may reflect ovarian response and embryo allocation. Methods: This retrospective cohort included 7,778 in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycle records. Existing pregnancy analyses used 4,273 positive-transfer records. A linked clinical and laboratory source export enabled post hoc analyses using recorded extended culture counts, retrieval order, transfer dates, thawing records, and source-identifier grouping. Results: The original high-versus-low P/MII rate ratio for blastocysts per recorded 2PN zygote was 0.796 (95% CI 0.762–0.831). Among the same 5,821 culture-positive records, the adjusted rate ratio was 0.934 (0.902–0.968) with a 2PN denominator and 0.974 (0.945–1.005; P = 0.101) with the recorded culture denominator. The continuous culture-count association remained small (aRR 0.993 per 0.01, 0.989–0.997). The source recorded 6,148 first and 1,630 later retrievals. In 3,526 first-retrieval, date-consistent records without thawing evidence, the ratio term after inclusion of progesterone and MII was associated with clinical pregnancy flags (aOR 0.952, 0.919–0.986; P = 0.006) but was uncertain for live birth flags (0.968, 0.935–1.002; P = 0.067). Source-identifier-grouped live birth areas under the receiver operating characteristic curve (AUCs) were 0.623 with the components, 0.623 with P/MII, and 0.624 with all three. Conclusions: Recorded associations depended on the culture population, denominator, and outcome. Incremental clinical usefulness was not established. These data do not support a physiological ratio mechanism or a clinical cutoff for trigger-day or freeze-all decisions.
SN - 1664-2392
ER -